Post Profile






Gene therapy offers hope for treatment of sickle cell anaemia

Scientists to begin trials for treatment to overcome inherited disease that affects 300,000 newborn babies a year Scientists are finalising plans to use gene therapy to treat one of the world’s most widespread inherited diseases – sickle cell anaemia. The technique could begin trials next year, say researchers. About 300,000 babies are born globally with sickle cell disease.
read more

share

Related Posts


New stem cell gene therapy gives hope to prevent inherited neurological disease

Academics / General Science : Science Codex

Scientists from The University of Manchester have used stem cell gene therapy to treat a fatal genetic brain disease in mice for the first time. The method was used to treat Sanfilippo – a fatal inherited condition which causes prog...

Stem cell gene therapy used to treat a fatal genetic brain disease in mice for the first time

Health : Medical News Today

Scientists from The University of Manchester have used stem cell gene therapy to treat a fatal genetic brain disease in mice for the first time. The method was used to treat Sanfilippo - a fatal inherited condition which causes prog...

UCLA Stem Cell Gene Therapy for Sickle Cell Disease Advances Toward Clinical Trials

Health : Newswise Medical News

UCLA Researchers have successfully established the foundation for using hematopoietic (blood-producing) stem cells from the bone marrow of patients with sickle cell disease to treat the disease.

Hydroxycarbamide Therapy Should Become The Standard Treatment For All Children With Sickle Cell Disease (Baby Hug Trial)

Health : Medical News Today

The first randomised double-blind trial to examine the effect of hydroxycarbamide (previously hydroxyurea) in very young children with sickle-cell anaemia shows that the drug is safe and significantly reduces pain and other common c...

Potential Cure For Children With Sickle Cell Disease Evaluated In Nationwide Research Study

Health : Medical News Today

A first-of-its-kind clinical trial may provide new treatment options to children with sickle cell disease (SCD), an inherited blood disorder that affects 70,000 people in the United States. The Sickle Cell Unrelated Transplant (SCUR...

Comments


Copyright © 2016 Regator, LLC